Most clinical-stage biotechs celebrate Phase 3 wins without realizing their GxP infrastructure isn't ready for NDA-level FDA scrutiny. Here are the 5 gaps that derail NDA submissions — and how to close them.
Join USDM at BoxWorks 2026 to explore AI-driven content management excellence with compliance built-in. Power smarter, compliant content management for life sciences.
FDA’s QMSR and updated inspection program (CP 7382.850) put UDI compliance at the center of medical device inspections. Learn how UDI ties to ISO 13485 alignment, GUDID accuracy, and inspection readiness—and how to prepare.
